The Differences Levels of RANTES and PF4 Based on the Storage of Platelet Concentrate

Ni Made Rindra Hermawathi, Betty Agustina Tambunan, Arifoel Hajat


Blood component transfusion is often used as the primary therapy as it is still considered safe. Platelet Concentrate (PC) transfusion plays a critical role in preventing bleeding in patients with severe thrombocytopenia. Allergic reactions are the most frequent transfusion reactions after PC administration. Regulated on Activation Normal T-Cell Expressed and Secreted (RANTES) and Platelet Factor 4 (PF4) cytokines released by platelets during PC storage are responsible for allergic reactions after transfusion. The purpose of this study was to analyze changes in RANTES and PF4 levels during PC storage. This study was an observational analytical research with a time series design carried out at the Clinical Pathology Laboratory and Blood Bank of the Dr. Soetomo Hospital, Surabaya, from June to July 2019. RANTES and PF4 levels in 27 bags derived from Platelet Rich Plasma (PRP) on storage for day 1, day 3, and day five were measured using the ELISA sandwich method. Subject same variant test or Friedman test was used for statistical analysis. The results showed no significant differences in RANTES and PF4 levels based on the storage duration of PCs on days 1, 3, and 5, with p=0.717, and p=0.614, respectively. There was no difference in the storage of PCs from day 1 to day five, and there was no effect on allergic reactions after PC transfusion.


Regulated upon activation, normal T-cell expressed and presumably secreted, platelet factor 4, platelet concentrate

Full Text:



Kemenkes RI. Peraturan Menteri Kesehatan Republik

Indonesia nomor 91 tahun 2015 tentang standar

pelayanan tranfusi darah. 2016; 6-7.

Forest SK, Hod EA. Management of the platelet

refractory patient. Hematology/Oncology Clinics of

North America, 2016; 30(3): 665-77.

Sut C, Tariket S, Aubron C. The non-hemostatic aspect

of transfused platelets. Frontiers in Medicine, 2018;

: 1-11.

Ahmed A, Leheta O, Younes S. In-vitro assessment of

platelet storage lesion in leukoreduced random

donor platelet concentrate. Blood Transfusion, 2010;

(1): 28-35.

Armenia D, Tambunan BA. Evaluation of storage

length to blood component platelet concentrate

quality in the Blood Bank, Dr. Soetomo General

Hospital Surabaya Indonesia. Indian Journal of

Forensic Medicine & Toxicology, 2020; 14(4): 908-913.

Seghatchian J. Platelet storage lesion: An update on

the impact of various leukoreduction processes on

the biological response modifiers. Transfusion and

Apheresis Science, 2006; 34(1): 125-30.

Elabscience. Manual book-human RANTES (Regulated on Activation, Normal T-Cell Expressed

and Secreted) ELISA kit. 2017; 1-11.

Elabscience. Manual book-human PF4 (Platelet Factor

ELISA kit. 2017; 1-11.

Shrivastava M. The platelet storage lesion. Transfusion

and Apheresis Science, 2009; 41(2): 105-13.

Wadhwa M, Seghatchian MJ, Dilger P, Sands D,

Krailadisiri P, et al. Cytokines in WBC-reduced

apheresis PCs during storage: A comparison of two

WBC-reduction methods. Transfusion, 2000; 40(9):


Shukla R, Patel T, Gupte S. Release of cytokines in

stored whole blood and red cell concentrate: Effect of

leukoreduction. Asian Journal of Transfusion Science,

; 9(2): 145-149.

Tormey C, Stack G. Use of a cytokine-release assay to

demonstrate loss of platelet secretory capacity during

blood bank processing and storage. Archives of

Pathology & Laboratory Medicine, 2014; 138(11):




  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.